Loading…
Pulmonary Vascular Smooth Muscle Relaxation by cAMP-Mediated Pathways
Adenosine 3′,5′-cyclic monophosphate (cAMP)-mediated pulmonary vascular smooth relaxation is a principle mechanism of pulmonary vasomotor control. The purpose of this study was to compare the potency and efficacy of the following receptor-linked pathways of pulmonary vasorelaxation which are mediate...
Saved in:
Published in: | The Journal of surgical research 1996-03, Vol.61 (2), p.444-448 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c434t-55a5ad556966ccbc15048646d09654275958d8f327c8c125cad56cb9e12a52333 |
---|---|
cites | |
container_end_page | 448 |
container_issue | 2 |
container_start_page | 444 |
container_title | The Journal of surgical research |
container_volume | 61 |
creator | Fullerton, David A. Agrafojo, Jeanette McIntyre, Jr, Robert C. |
description | Adenosine 3′,5′-cyclic monophosphate (cAMP)-mediated pulmonary vascular smooth relaxation is a principle mechanism of pulmonary vasomotor control. The purpose of this study was to compare the potency and efficacy of the following receptor-linked pathways of pulmonary vasorelaxation which are mediated by cAMP: (1) β2-adrenergic receptor activation (response to isoproterenol) (2) Adenosine A2-receptor activation (response to adenosine) (3) Prostaglandin EP2-receptor activation (response to prostaglandin E1) (4) Histamine H2-receptor activation (response to the H2-receptor agonist dimaprit) and (5) Purinergic P2-receptor activation (response to ADP). Cumulative concentration-response curves were generated in isolated rat pulmonary artery rings suspended on individual tensiometers. Five rats/ten pulmonary artery rings were studied for each agonist. Relaxation by β2-adrenergic receptor activation was most effective as complete ring relaxation was achieved at 10−6Misoproterenol with a median effective dose of 10−7M. A2, P2, and EP2-receptor activation all achieved complete ring relaxation at concentrations up to 10−3M.Relaxation by H2-receptor activation was least effective as 30% ring tension remained at a concentration of 10−3M.We conclude that these receptor-linked pathways, although all mediated through cAMP, have significant differences in potency and efficacy. |
doi_str_mv | 10.1006/jsre.1996.0143 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78026584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022480496901432</els_id><sourcerecordid>78026584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-55a5ad556966ccbc15048646d09654275958d8f327c8c125cad56cb9e12a52333</originalsourceid><addsrcrecordid>eNp1kElPAjEUgBujQUSv3kzmYLwNdp_2SAguCUTidm3KmxKGzILtjMq_twTCzdPLy_ve9iF0TfCQYCzv18G7IdFaDjHh7AT1CdYiVTJjp6iPMaUpV5ifo4sQ1jjmOmM91FNSSElpH03mXVk1tfXb5NMG6Errk7eqadpVMusClC55daX9tW3R1Mlim8BoNk9nLi9s6_JkbtvVj92GS3S2tGVwV4c4QB8Pk_fxUzp9eXwej6YpcMbbVAgrbC6E1FICLIAIzJXkMsdaCk4zoYXK1ZLRDBQQKiDCEhbaEWoFZYwN0N1-7sY3X50LramKAK4sbe2aLphMYSqF4hEc7kHwTYiGlmbjiyp-aQg2O29m583svJmdt9hwc5jcLSqXH_GDqFi_PdSjJVsuva2hCEeMxb0a44ipPeaihe_CeROgcDVEYd5Ba_Km-O-CP1uVh6I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78026584</pqid></control><display><type>article</type><title>Pulmonary Vascular Smooth Muscle Relaxation by cAMP-Mediated Pathways</title><source>ScienceDirect Freedom Collection</source><creator>Fullerton, David A. ; Agrafojo, Jeanette ; McIntyre, Jr, Robert C.</creator><creatorcontrib>Fullerton, David A. ; Agrafojo, Jeanette ; McIntyre, Jr, Robert C.</creatorcontrib><description>Adenosine 3′,5′-cyclic monophosphate (cAMP)-mediated pulmonary vascular smooth relaxation is a principle mechanism of pulmonary vasomotor control. The purpose of this study was to compare the potency and efficacy of the following receptor-linked pathways of pulmonary vasorelaxation which are mediated by cAMP: (1) β2-adrenergic receptor activation (response to isoproterenol) (2) Adenosine A2-receptor activation (response to adenosine) (3) Prostaglandin EP2-receptor activation (response to prostaglandin E1) (4) Histamine H2-receptor activation (response to the H2-receptor agonist dimaprit) and (5) Purinergic P2-receptor activation (response to ADP). Cumulative concentration-response curves were generated in isolated rat pulmonary artery rings suspended on individual tensiometers. Five rats/ten pulmonary artery rings were studied for each agonist. Relaxation by β2-adrenergic receptor activation was most effective as complete ring relaxation was achieved at 10−6Misoproterenol with a median effective dose of 10−7M. A2, P2, and EP2-receptor activation all achieved complete ring relaxation at concentrations up to 10−3M.Relaxation by H2-receptor activation was least effective as 30% ring tension remained at a concentration of 10−3M.We conclude that these receptor-linked pathways, although all mediated through cAMP, have significant differences in potency and efficacy.</description><identifier>ISSN: 0022-4804</identifier><identifier>EISSN: 1095-8673</identifier><identifier>DOI: 10.1006/jsre.1996.0143</identifier><identifier>PMID: 8656622</identifier><identifier>CODEN: JSGRA2</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adenosine - pharmacology ; Adenosine Diphosphate - pharmacology ; Alprostadil - pharmacology ; Animals ; Biological and medical sciences ; Blood vessels and receptors ; Cyclic AMP - physiology ; Dimaprit - pharmacology ; Dose-Response Relationship, Drug ; Fundamental and applied biological sciences. Psychology ; Isoproterenol - pharmacology ; Male ; Muscle, Smooth, Vascular - physiology ; Pulmonary Artery - physiology ; Rats ; Rats, Sprague-Dawley ; Receptors, Adrenergic, beta-2 - physiology ; Vasodilation - drug effects ; Vertebrates: cardiovascular system</subject><ispartof>The Journal of surgical research, 1996-03, Vol.61 (2), p.444-448</ispartof><rights>1996 Academic Press</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-55a5ad556966ccbc15048646d09654275958d8f327c8c125cad56cb9e12a52333</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3026900$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8656622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fullerton, David A.</creatorcontrib><creatorcontrib>Agrafojo, Jeanette</creatorcontrib><creatorcontrib>McIntyre, Jr, Robert C.</creatorcontrib><title>Pulmonary Vascular Smooth Muscle Relaxation by cAMP-Mediated Pathways</title><title>The Journal of surgical research</title><addtitle>J Surg Res</addtitle><description>Adenosine 3′,5′-cyclic monophosphate (cAMP)-mediated pulmonary vascular smooth relaxation is a principle mechanism of pulmonary vasomotor control. The purpose of this study was to compare the potency and efficacy of the following receptor-linked pathways of pulmonary vasorelaxation which are mediated by cAMP: (1) β2-adrenergic receptor activation (response to isoproterenol) (2) Adenosine A2-receptor activation (response to adenosine) (3) Prostaglandin EP2-receptor activation (response to prostaglandin E1) (4) Histamine H2-receptor activation (response to the H2-receptor agonist dimaprit) and (5) Purinergic P2-receptor activation (response to ADP). Cumulative concentration-response curves were generated in isolated rat pulmonary artery rings suspended on individual tensiometers. Five rats/ten pulmonary artery rings were studied for each agonist. Relaxation by β2-adrenergic receptor activation was most effective as complete ring relaxation was achieved at 10−6Misoproterenol with a median effective dose of 10−7M. A2, P2, and EP2-receptor activation all achieved complete ring relaxation at concentrations up to 10−3M.Relaxation by H2-receptor activation was least effective as 30% ring tension remained at a concentration of 10−3M.We conclude that these receptor-linked pathways, although all mediated through cAMP, have significant differences in potency and efficacy.</description><subject>Adenosine - pharmacology</subject><subject>Adenosine Diphosphate - pharmacology</subject><subject>Alprostadil - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood vessels and receptors</subject><subject>Cyclic AMP - physiology</subject><subject>Dimaprit - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Isoproterenol - pharmacology</subject><subject>Male</subject><subject>Muscle, Smooth, Vascular - physiology</subject><subject>Pulmonary Artery - physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Adrenergic, beta-2 - physiology</subject><subject>Vasodilation - drug effects</subject><subject>Vertebrates: cardiovascular system</subject><issn>0022-4804</issn><issn>1095-8673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNp1kElPAjEUgBujQUSv3kzmYLwNdp_2SAguCUTidm3KmxKGzILtjMq_twTCzdPLy_ve9iF0TfCQYCzv18G7IdFaDjHh7AT1CdYiVTJjp6iPMaUpV5ifo4sQ1jjmOmM91FNSSElpH03mXVk1tfXb5NMG6Errk7eqadpVMusClC55daX9tW3R1Mlim8BoNk9nLi9s6_JkbtvVj92GS3S2tGVwV4c4QB8Pk_fxUzp9eXwej6YpcMbbVAgrbC6E1FICLIAIzJXkMsdaCk4zoYXK1ZLRDBQQKiDCEhbaEWoFZYwN0N1-7sY3X50LramKAK4sbe2aLphMYSqF4hEc7kHwTYiGlmbjiyp-aQg2O29m583svJmdt9hwc5jcLSqXH_GDqFi_PdSjJVsuva2hCEeMxb0a44ipPeaihe_CeROgcDVEYd5Ba_Km-O-CP1uVh6I</recordid><startdate>19960301</startdate><enddate>19960301</enddate><creator>Fullerton, David A.</creator><creator>Agrafojo, Jeanette</creator><creator>McIntyre, Jr, Robert C.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960301</creationdate><title>Pulmonary Vascular Smooth Muscle Relaxation by cAMP-Mediated Pathways</title><author>Fullerton, David A. ; Agrafojo, Jeanette ; McIntyre, Jr, Robert C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-55a5ad556966ccbc15048646d09654275958d8f327c8c125cad56cb9e12a52333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adenosine - pharmacology</topic><topic>Adenosine Diphosphate - pharmacology</topic><topic>Alprostadil - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood vessels and receptors</topic><topic>Cyclic AMP - physiology</topic><topic>Dimaprit - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Isoproterenol - pharmacology</topic><topic>Male</topic><topic>Muscle, Smooth, Vascular - physiology</topic><topic>Pulmonary Artery - physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Adrenergic, beta-2 - physiology</topic><topic>Vasodilation - drug effects</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fullerton, David A.</creatorcontrib><creatorcontrib>Agrafojo, Jeanette</creatorcontrib><creatorcontrib>McIntyre, Jr, Robert C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of surgical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fullerton, David A.</au><au>Agrafojo, Jeanette</au><au>McIntyre, Jr, Robert C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulmonary Vascular Smooth Muscle Relaxation by cAMP-Mediated Pathways</atitle><jtitle>The Journal of surgical research</jtitle><addtitle>J Surg Res</addtitle><date>1996-03-01</date><risdate>1996</risdate><volume>61</volume><issue>2</issue><spage>444</spage><epage>448</epage><pages>444-448</pages><issn>0022-4804</issn><eissn>1095-8673</eissn><coden>JSGRA2</coden><abstract>Adenosine 3′,5′-cyclic monophosphate (cAMP)-mediated pulmonary vascular smooth relaxation is a principle mechanism of pulmonary vasomotor control. The purpose of this study was to compare the potency and efficacy of the following receptor-linked pathways of pulmonary vasorelaxation which are mediated by cAMP: (1) β2-adrenergic receptor activation (response to isoproterenol) (2) Adenosine A2-receptor activation (response to adenosine) (3) Prostaglandin EP2-receptor activation (response to prostaglandin E1) (4) Histamine H2-receptor activation (response to the H2-receptor agonist dimaprit) and (5) Purinergic P2-receptor activation (response to ADP). Cumulative concentration-response curves were generated in isolated rat pulmonary artery rings suspended on individual tensiometers. Five rats/ten pulmonary artery rings were studied for each agonist. Relaxation by β2-adrenergic receptor activation was most effective as complete ring relaxation was achieved at 10−6Misoproterenol with a median effective dose of 10−7M. A2, P2, and EP2-receptor activation all achieved complete ring relaxation at concentrations up to 10−3M.Relaxation by H2-receptor activation was least effective as 30% ring tension remained at a concentration of 10−3M.We conclude that these receptor-linked pathways, although all mediated through cAMP, have significant differences in potency and efficacy.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8656622</pmid><doi>10.1006/jsre.1996.0143</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-4804 |
ispartof | The Journal of surgical research, 1996-03, Vol.61 (2), p.444-448 |
issn | 0022-4804 1095-8673 |
language | eng |
recordid | cdi_proquest_miscellaneous_78026584 |
source | ScienceDirect Freedom Collection |
subjects | Adenosine - pharmacology Adenosine Diphosphate - pharmacology Alprostadil - pharmacology Animals Biological and medical sciences Blood vessels and receptors Cyclic AMP - physiology Dimaprit - pharmacology Dose-Response Relationship, Drug Fundamental and applied biological sciences. Psychology Isoproterenol - pharmacology Male Muscle, Smooth, Vascular - physiology Pulmonary Artery - physiology Rats Rats, Sprague-Dawley Receptors, Adrenergic, beta-2 - physiology Vasodilation - drug effects Vertebrates: cardiovascular system |
title | Pulmonary Vascular Smooth Muscle Relaxation by cAMP-Mediated Pathways |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T14%3A23%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulmonary%20Vascular%20Smooth%20Muscle%20Relaxation%20by%20cAMP-Mediated%20Pathways&rft.jtitle=The%20Journal%20of%20surgical%20research&rft.au=Fullerton,%20David%20A.&rft.date=1996-03-01&rft.volume=61&rft.issue=2&rft.spage=444&rft.epage=448&rft.pages=444-448&rft.issn=0022-4804&rft.eissn=1095-8673&rft.coden=JSGRA2&rft_id=info:doi/10.1006/jsre.1996.0143&rft_dat=%3Cproquest_cross%3E78026584%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c434t-55a5ad556966ccbc15048646d09654275958d8f327c8c125cad56cb9e12a52333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78026584&rft_id=info:pmid/8656622&rfr_iscdi=true |